Related Experiment Video

Updated: Apr 23, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

12.4K

Knockdown of CETN1 inhibits breast cancer cells proliferation

Xu Shuangta1, He Yali, Zheng Zhengrong

  • 1Oncology Department, Fujian, Hong Kong, China.

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|September 28, 2014
PubMed
Abstract

Insights

The study found that Centromere Protein N (CETN1) is overexpressed in breast cancer and drives tumor growth and metastasis. Inhibiting CETN1 significantly reduced cancer cell proliferation and spread, suggesting it as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer is a complex disease driven by genetic and protein alterations.
  • Identifying key regulators of breast carcinogenesis is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of Centromere Protein N (CETN1) in breast cancer progression.
  • To determine if CETN1 influences breast cancer growth and metastasis.

Main Methods:

  • CETN1 expression was quantified in breast tissue using immunohistochemistry (IHC).
  • Human breast carcinoma cell lines with metastatic potential were utilized.
  • Cell proliferation was assessed via MTS assay, and cell cycle progression was analyzed.
  • Western blot was employed to analyze CETN1 levels in tumor cells.

Main Results:

  • Overexpression of CETN1 was observed in breast cancer cells with initially low CETN1 expression.
  • Knockdown of CETN1 using lentiviral shRNA significantly inhibited breast cancer cell proliferation.
  • CETN1 knockdown also suppressed tumor growth and metastasis in experimental models.

Conclusions:

  • Centromere Protein N (CETN1) is significantly overexpressed in breast cancer tissues.
  • CETN1 promotes cancer cell proliferation, tumor growth, and metastasis.
  • Targeting CETN1 may represent a novel therapeutic strategy for breast cancer.

More Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

9.7K
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.3K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K